Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial
Open Access
- 22 December 2018
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-13
Abstract
Developing non-pharmacological interventions with strong potential to prevent or delay the onset of Alzheimer’s disease (AD) in high-risk populations is critical. Aerobic exercise and cognitive training are two promising interventions. Aerobic exercise increases aerobic fitness, which in turn improves brain structure and function, while cognitive training improves selective brain function intensively. Hence, combined aerobic exercise and cognitive training may have a synergistic effect on cognition by complementary strengthening of different neural functions. Few studies have tested the effects of such a combined intervention, and the findings have been discrepant, largely due to varying doses and formats of the interventions. The purpose of this single-blinded, 2 × 2 factorial phase II randomized controlled trial is to test the efficacy and synergistic effects of a 6-month combined cycling and speed of processing training intervention on cognition and relevant mechanisms (aerobic fitness, cortical thickness, and functional connectivity in the default mode network) in older adults with amnestic mild cognitive impairment. This trial will randomize 128 participants equally to four arms: cycling and speed of processing, cycling only, speed of processing only, or attention control for 6 months, and then follow them for another 12 months. Cognition and aerobic fitness will be assessed at baseline and at 3, 6, 12, and 18 months; cortical thickness and functional connectivity at baseline and at 6, 12, and 18 months; Alzheimer’s disease (AD) conversion at 6, 12, and 18 months. The specific aims are to (1) determine the efficacy and synergistic effects of the combined intervention on cognition over 6 months, (2) examine the underlying mechanisms of the combined intervention, and (3) calculate the long-term effect sizes of the combined intervention on cognition and AD conversion. The analysis will use intention-to-treat and linear mixed-effects modeling. This trial will be among the first to test the synergistic effects on cognition and mechanisms (relevant to Alzheimer’s-associated neurodegeneration) of a uniquely conceptualized and rigorously designed aerobic exercise and cognitive training intervention in older adults with mild cognitive impairment. It will advance Alzheimer’s prevention research by providing precise effect-size estimates of the combined intervention. ClinicalTrials.gov, NCT03313895 . Registered on 18 October 2017.Keywords
Funding Information
- National Institute on Aging (R01AG055469-01A1)
This publication has 66 references indexed in Scilit:
- Effects of simultaneously performed cognitive and physical training in older adultsBMC Neuroscience, 2013
- Computerized Cognitive Training with Older Adults: A Systematic ReviewPLOS ONE, 2012
- Use it or lose it: How neurogenesis keeps the brain fit for learningBehavioural Brain Research, 2012
- Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: The Seniors Health and Activity Research Program Pilot (SHARP-P) Study, a randomized controlled trialBMC Geriatrics, 2011
- Exercise moderates age-related atrophy of the medial temporal lobeNeurobiology of Aging, 2011
- Psychomotor Speed and Functional Brain MRI 2 Years After Completing a Physical Activity TreatmentThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Aerobic fitness is associated with hippocampal volume in elderly humansHippocampus, 2009
- Cardiorespiratory fitness and brain atrophy in early Alzheimer diseaseNeurology, 2008
- Selective changes of resting-state networks in individuals at risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's diseaseThe Lancet Neurology, 2005